Core Insights - Cannabis stocks experienced significant movement following President Trump's endorsement of cannabidiol (CBD) for seniors, highlighting potential health benefits [1] - Major marijuana stocks saw substantial gains, with Tilray Brands increasing by 42% and Aurora Cannabis by 25%, although some of these gains were later reversed [2] Company Overview - Constellation Brands is a significant shareholder in Canopy Growth, holding approximately 26 million shares through its shell company, which could represent about 14% of Canopy's stock if converted [3] - Constellation Brands is the third-largest beer company in the U.S., also producing high-end wine and spirits, with notable brands like Corona and Kim Crawford [4] Financial Performance - Constellation Brands has a market capitalization of $24.5 billion and has seen a year-to-date decline of 37% in 2025, underperforming competitors like Boston Beer and Molson Coors [5] - The stock is currently considered overvalued with a price-to-earnings ratio of 46.4, significantly higher than its 10-year median of 25.8 [5] Dividend Information - Constellation Brands offers a dividend yield of 3%, which is above the sector average of 1.9%, with the next payment scheduled for November 13, 2025 [6]

Core Insights - Curaleaf Holdings, Inc. reported in line financial results for Q2 2025 and announced plans to expand international operations into Turkey [1] Financial Performance - The financial results for Q2 2025 were consistent with expectations, indicating stable performance [1] Expansion Plans - The company is set to begin its expansion into Turkey, marking a significant step in its international operations [1]

Group 1: Market Overview - Tech stocks are rallying following OpenAI's $500 billion valuation, contributing to a significant increase in market enthusiasm, particularly among chipmakers, which added approximately $200 billion in market value [4][2][1] - The S&P 500 is on track for its 30th all-time high this year, reflecting strong investor sentiment and market performance [3][2] - The ongoing government shutdown is causing uncertainty in economic activity, which may influence the Federal Reserve's decisions regarding interest rate cuts [120][119] Group 2: Company Insights - Tesla reported record vehicle sales, delivering 497,000 vehicles in the latest quarter, marking a 7.4% increase year-over-year, which has driven its stock to record highs [31][32] - Rivian has narrowed its annual delivery guidance due to the loss of consumer tax incentives, now expecting to deliver between 41,500 to 43,500 vehicles this year [33] - General Motors (GM) is experiencing strong sales growth, with a 10% year-over-year increase, and has announced a $1 billion impact from tariffs while investing in U.S. manufacturing [56][57] Group 3: Investment Strategies - Investment strategies are focusing on sectors like AI, robotics, and quantum technologies, with a recommendation to buy on dips and hold strong positions in leading tech names [10][12][11] - The sentiment among retail investors is cautiously optimistic, with concerns about high valuations and potential market corrections [78][81] - Gold is gaining renewed interest as a safe haven asset, with predictions of prices reaching $4,000 per ounce by mid-2026, driven by macroeconomic uncertainties and strong demand [101][106]

Core Viewpoint - Cannara Biotech Inc. intends to settle approximately $6.2 million of indebtedness through the issuance of common shares to Olymbec Investments Inc. as part of a convertible debenture agreement [1][5][6]. Debt Settlement - The company plans to settle $4.7 million in principal and approximately $1.5 million in accrued interest under the Olymbec Convertible Debenture [1][2]. - The original principal amount of the Olymbec Convertible Debenture was $5.7 million, with a prior repayment of $1 million reducing the outstanding principal to $4.7 million [2]. Share Issuance Details - Cannara proposes to issue 3,462,763 common shares at a deemed price of $1.80 per share to satisfy the outstanding indebtedness, with 851,652 shares representing the repayment of interest [3]. - The issuance is subject to the policies of the TSX Venture Exchange and requires their review and approval [4]. Related Party Transaction - The transaction is classified as a "related party transaction" due to Mr. Derek Stern's significant interest in Olymbec, and Cannara intends to rely on an exemption from minority shareholder approval requirements [5]. - Following the share issuance, Olymbec will hold approximately 25.47% of Cannara's issued and outstanding common shares [6]. Corporate Governance - The Proposed Olymbec Share Issuance has been approved by independent directors of the company [7]. Investor Relations - Cannara granted 40,000 stock options to Bristol Capital Ltd. for investor relations services, with each option exercisable at $1.80 per common share [8].

Core Insights - Tilray Brands, Inc. is a significant player in the cannabis industry, known for its diverse product offerings and strategic acquisitions, including craft beer brands from Anheuser-Busch InBev, which has helped balance its revenue streams [1] - The company is set to release its quarterly earnings on October 9, 2025, with an estimated EPS of -$0.03, reflecting a 25% improvement year-over-year, and projected revenue of approximately $205.75 million, marking a 3.39% increase from the previous year [2][6] - Despite a recent stock price decline of 4.34% to $1.66, Tilray's stock has surged 38.4% over the past month, outperforming the Medical sector and the S&P 500, driven by political news and increased trading volume [3][6] Financial Metrics - Tilray's financial metrics indicate a complex valuation scenario, with a price-to-sales ratio of approximately 1.60 and an enterprise value to sales ratio of 1.61, suggesting reasonable valuation relative to sales [4] - The company has a negative price-to-earnings ratio and earnings yield, indicating current unprofitability, alongside a negative enterprise value to operating cash flow ratio, highlighting challenges in generating cash flow [4] - Despite these challenges, Tilray maintains a strong cash position, a low debt-to-equity ratio of 0.16, and a current ratio of 2.46, reflecting financial stability and the ability to cover short-term liabilities [5]

Core Points - Curaleaf Holdings, Inc. announced the establishment of an automatic securities disposition plan (ASDP) by Executive Vice Chairman Joseph F. Lusardi, effective September 30, 2025, to facilitate the orderly exercise of options expiring in March 2026 and the sale of subordinate voting shares to cover anticipated taxes [1][2][3] Group 1: ASDP Details - The ASDP allows for trades to be made under pre-arranged instructions when executives do not possess material undisclosed information, ensuring compliance with United States and Canadian securities laws [2][3] - Sales of subordinate voting shares will be conducted by an independent broker following the ASDP's trading parameters, and it is possible that not all shares will be sold during the ASDP term [3] - The ASDP prohibits Mr. Lusardi from influencing the sales and requires that all transactions be reported in accordance with applicable securities laws, with notations indicating they are related to the ASDP [4][5] Group 2: Company Overview - Curaleaf is a leading international provider of consumer cannabis products, focusing on enhancing lives through the power of cannabis, with a strong presence across the supply chain [6] - The company operates under various brands, including Curaleaf, Select, Grassroots, Find, Anthem, and The Hemp Company, and is recognized for quality and reliability in the cannabis industry [6]

Group 1 - The article suggests that President Trump may leverage cannabis rescheduling to gain support during the midterm elections, potentially benefiting the Amplify Alternative Harvest ETF [1] - The author emphasizes the importance of observing megatrends and technological advancements to identify investment opportunities, despite the challenges in spotting them [1] - The focus is on the fundamentals of companies, including leadership quality and product pipeline, as essential factors for uncovering investment opportunities [1] Group 2 - The author has experience in evaluating startups and emerging industries, indicating a strong background in assessing market potential [1] - There is a noted interest in macrotrends and futurism, which may influence investment strategies in the evolving market landscape [1] - The article highlights the significance of marketing and business strategy, particularly for medium-sized companies and startups, in driving growth and investment potential [1]

Key Points President Trump posted a video suggesting that seniors would benefit from hemp-derived CBD. He's also suggested reclassifying marijuana on a federal level. 10 stocks we like better than Tilray Brands › Marijuana stocks are getting some attention this week following new interest from President Donald Trump. Trump on Sunday posted a video on his Truth Social account that promoted the health benefits of hemp-derived CBD for seniors, suggesting it could be included under Medicare. The video ...

Core Points - InHouse™ has launched its second annual Help on the Homefront campaign to support veterans with housing costs and home improvements [1][4] - The campaign runs from October 1 to November 30, 2025, offering qualifying veterans a chance to win $5,000 to alleviate housing financial burdens [2] - One winner will be selected from each of four MariMed retail markets: Maryland, Massachusetts, Delaware, and Illinois [2] Company Overview - InHouse is a value-priced cannabis brand under MariMed Inc., offering a variety of high-quality products including flower, vapes, and gummies [5] - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities [6] - The company has a portfolio of award-winning cannabis brands, including InHouse, and is committed to excellence and growth in the cannabis industry [6]

Core Points - InHouse™ has launched its second annual Help on the Homefront campaign to support veterans with housing costs and home improvements, running from October 1 to November 30, 2025 [1][2] - The campaign aims to raise awareness about veteran housing challenges and homelessness, with one veteran from each of four states (Maryland, Massachusetts, Delaware, and Illinois) eligible to win $5,000 [1][2] - Veterans aged 21 and over can enter the contest either in-store at MariMed's Thrive dispensaries or online, with no purchase necessary [3] Company Overview - InHouse is a cannabis brand under MariMed Inc., offering a range of high-quality cannabis products including flower, vapes, and gummies [5] - MariMed Inc. is recognized as a leading multi-state cannabis operator, known for its innovative cultivation, production, and retail facilities, and has a portfolio of award-winning cannabis brands [6]